• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Alfuzosin-[13C,d3]

General Information
Catalog: BLP-003255
Molecular Formula: C1813CH24D3N5O4
Molecular Weight: 393.46
Chemical Structure
Alfuzosin-[13C,d3]
Description A labelled analog of Alfuzosin. Alfuzosin is a pharmaceutical drug of the alpha-1 blocker class. It works by relaxing the muscles in the prostate and bladder neck. It is used to treat benign prostatic hyperplasia (BPH). It offers an alternative to prostatectomy in patients who require surgery but are unfit for this treatment, and in patients requiring symptomatic relief while awaiting surgery. It is marketed in the United States by Sanofi Aventis under the brand name Uroxatral. It was approved by the FDA for treatment of BPH in June 2003.
Synonyms N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(13C,2H3)methylamino]propyl}oxolane-2-carboxamide; 2-furancarboxamide, N-[3-[(5-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-
IUPAC Name N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-(trideuterio(1-13C)methyl)amino]propyl]oxolane-2-carboxamide
Related CAS 81403-80-7 (unlabelled)
Canonical SMILES CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC
InChI InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)/i1+1D3
InChI Key WNMJYKCGWZFFKR-KQORAOOSSA-N

Interested in our Service & Products?
Need detailed information?

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All Rights Reserved.
Inquiry Basket